Answers are grounded in this paper and cite their sources.
BACKGROUND: Acute kidney injury (AKI) pathophysiology and repair are heterogenous processes, and clinical outcomes are difficult to predict. As a result, promising treatments in preclinical models have failed to translate to human subjects, and treatment options for AKI are primarily supportive. SUMMARY: To address this, one of the AKI and CRRT 2025 preconference symposium plenary sessions showcased cutting-edge translational work to guide the scientific community of AKI investigators. Topics included those focused on stratifying risk for AKI reflected in the concept of kidney fitness, characterizing the molecular phenotypes of AKI, improving diagnostics, and identifying novel therapeutic targets. KEY MESSAGES: This article provides a review of these topics and a summary of how they address challenges to translating new therapies in AKI from bench to bedside.
No takes yet. Share an insight, caveat, or question.
Epler et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: